Use of mode of action in risk assessment: Past, present, and future

Regulatory Toxicology and Pharmacology

Volumn 42, Issue 1, 2005, Pages 3-14

  Clewell, Harvey ^a  

^a ENVIRON Health Sciences Institute   (United States)

Author keywords

Arsenic; Methodology; Mode of action; Risk assessment; Trichloroethylene

Indexed keywords

ARSENIC; ATRAZINE; BORON; BORON DERIVATIVE; CHLOROFORM; FORMALDEHYDE; ORGANOPHOSPHATE; PERCHLORIC ACID; TRICHLOROETHYLENE; VINYL CHLORIDE; VINYL DERIVATIVE;

CANCER RISK; DOSIMETRY; EVALUATION; GENOTOXICITY; HEALTH STATUS; HUMAN; MEDICAL INFORMATION; NONHUMAN; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; TOXICOKINETICS;

ANIMALIA;

EID: 19444378032     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yrtph.2005.01.008     Document Type: Article

References (60)

1. C.O. Abernathy, W.R. Chappell, M.E. Meek, H. Gibb, and H.-R. Gho Is ingested inorganic arsenic a "threshold" carcinogen? Fundam. Appl. Toxicol. 29 1996 168 175
2. R. Albertini, H. Clewell, M.W. Himmelstein, E. Morinello, S. Olin, J. Preston, L. Scarano, M.T. Smith, J. Swenberg, R. Tice, and C. Travis The use of non-tumor data in cancer risk assessment: reflections on butadiene, vinyl chloride, and benzene Regul. Toxicol. Pharmacol. 37 1 2003 105 132
3. American Conference of Government Industrial Hygienists (ACGIH)., 2002. Documentation of the Threshold Limit Values and Biological Exposure Indices, seventh ed., ACGIH, Cincinnati, OH
4. M.E. Andersen, H.J. Clewell, M.L. Gargas, F.A. Smith, and R.H. Reitz Physiologically based pharmacokinetics and the risk assessment process for methylene chloride Toxicol. Appl. Pharmacol. 87 1987 185 205
5. M.E. Andersen, H.J. Clewell, E.T. Snow, and J.W. Yager Mode of action studies for assessing carcinogenic risks posed by inorganic arsenic W.R. Chappel C.O. Abernathy R.L. Calderon Arsenic exposure and health effects 1999 Elsevier Science Oxford, United Kingdom
6. H.A. Barton, and H.J. Clewell Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assessment Environ. Health Perspect. 108 Suppl. 2 2000 323 334
7. M.S. Bogdanffy, G. Daston, E.M. Faustman, C.A. Kimmel, G.L. Kimmel, J. Seed, and V. Vu Harmonization of cancer and noncancer risk assessment: proceedings of a consensus-building workshop Toxicol. Sci. 61 1 2001 18 31
8. M.S. Bogdanffy, D.R. Plowchalk, R. Sarangapani, T.B. Starr, and M.E. Andersen Mode-of-action-based dosimeters for interspecies extrapolation of vinyl acetate inhalation risk Inhal. Toxicol. 13 5 2001 377 396
9. R.J. Bull Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate Environ. Health Perspect. 108 Suppl. 2 2000 241 259
10. Chemical Industry Institute of Toxicology (CIIT), 1999. Formaldehyde: Hazard Characterization and Dose-Response Assessment for Carcinogenicity by the Route of Inhalation. Revised Edition. CIIT, 6 Davis Drive, Research Triangle Park, NC
11. L.H. Clark, R.W. Setzer, and H.A. Barton Framework for evaluation of physiologically based pharmacokinetic models for use in safety or risk assessment Risk Anal. 24 2004 1697 1718
12. H.J. Clewell Incorporating biological information in quantitative risk assessment: an example with methylene chloride Toxicology 102 1995 83 94
13. H. Clewell Research requirements for a biologically realistic cancer risk assessment for arsenic W.R. Chappel C.O. Abernathy R.L. Calderon Arsenic exposure and health effects IV 2001 Elsevier Science Oxford, United Kingdom
14. Clewell, H.J., Andersen, M.E., 1997. Report on the Trichloroethylene Workshop, Williamsburg, VA, 18-19 May 1995, AL/OE-TN-1997-0001, Armstrong Laboratory, Wright-Patterson AFB, OH
15. H.J. Clewell, and M.E. Andersen Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene Crit. Rev. Toxicol. 34 5 2004 385 445
16. H.J. Clewell, M.E. Andersen, and H.A. Barton A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment Environ. Health Perspect. 110 2002 85 93
17. H.J. Clewell, H.A. Barton, P.R. Gentry, A.M. Shipp, J.W. Yager, and M.E. Andersen Requirements for a biologically-realistic arsenic risk assessment Int. J. Toxicol. 18 2 1998 131 147
18. H.J. Clewell, P.R. Gentry, J.M. Gearhart, B.C. Allen, and M.E. Andersen Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model Sci. Total Environ. 274 1-3 2001 37 66
19. R.B. Conolly, J.S. Kimbell, D. Janszen, P.M. Schlosser, D. Kalisak, J. Preston, and F.J. Miller Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat Toxicol. Sci. 75 2 2003 432 447
20. R.B. Conolly, J.S. Kimbell, D. Janszen, P.M. Schlosser, D. Kalisak, J. Preston, and F.J. Miller Human respiratory tract cancer risks of inhaled formaldehyde: dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset Toxicol. Sci. 82 1 2004 279 296
21. R.B. Conolly, K.T. Morgan, M.E. Andersen, T.M. Monticello, and H.J. Clewell A biologically-based risk assessment strategy for inhaled formaldehyde Comments Toxicol. 4 1992 269 293
22. R.A. Corley, G.A. Bormett, and B.I. Ghanayem Physiologically-based pharmacokinetics of 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in rats and humans Toxicol. Appl. Pharmacol. 129 1994 61 79
23. R.A. Corley, D.A. Markham, C. Banks, P. Delorme, A. Masterman, and J.M. Houle Physiologically-based pharmacokinetics and the dermal absorption of 2-butoxyethanol vapors by humans Toxicol. Appl. Pharmacol. 39 1997 120 130
24. K.S. Crump, D. Hoel, C. Langley, and R. Peto Fundamental carcinogenic processes and their implications to low dose risk assessment Cancer Res. 36 1976 2973 2979
25. M.L. Dourson, S.P. Felter, and D. Robinson Evolution of science-based uncertainty factors in noncancer risk assessment Reg. Tox. Pharmacol. 24 1996 108 120
26. M.L. Dourson, and J. Stara Regulatory history and experimental support of uncertainty (safety) factors Reg. Tox. Pharmacol. 3 1983 224 238
27. A.J. Lehman, and O.G. Fitzhugh 100-fold margin of safety Assoc. Food Drug Off. U.S. Q. Bull. 18 1954 33 35
28. P.R. Gentry, T.R. Covington, M.E. Andersen, and H.J. Clewell Application of a physiologically-based pharmacokinetic model for isopropanol in the derivation of an RfD/RfC Reg. Toxicol. Pharmacol. 36 2002 51 68
29. L.T. Haber, A. Maier, Q. Zhao, J.S. Dollarhide, R.E. Savage, and M.L. Dourson Applications of mechanistic data in risk assessment: the past, present, and future Toxicol. Sci. 61 2001 32 39
30. D. Hattis, L. Erdreich, and M. Ballew Human variability in susceptibility to toxic chemicals-a preliminary analysis of pharmacokinetic data from normal volunteers Risk Anal. 7 4 1987 415 426
31. Y. Hu, X. Jin, and E.T. Snow Effect of arsenic on transcription factor AP-1 and NF-kappaB DNA binding activity and related gene expression Toxicol. Lett. 133 1 2002 33 45
32. International Agency for Research on Cancer (IARC), 1995. Dry Cleaning, some Solvents used in Dry Cleaning and Other Industrial Chemicals, Scand. J. Work Environ. Health 21, 310-312
33. International Programme on Chemical Safety (IPCS), 2001. Guidance Document for the use of Data in Development of Chemical-Specific Sdjustment Factors (CSAF) for Interspecies Differences and Human Variability in Dose/Concentration Response Assessment. WHO/PCS/01.4. World Health Organization, Geneva
34. Lee, E., 1999. A Physiologically Based Pharmacokinetic Model for the Ingestion of Arsenic in Humans. Ph.D. Dissertation. University of California, Irvine, California
35. National Research Council (NRC), 1999. Arsenic in Drinking Water. National Academy Press, Washington DC
36. S.H. Safe Development validation and problems with the toxic equivalency factor approach for risk assessment of dioxins and related compounds J. Anim. Sci. 76 1 1998 134 141
37. K. Salnikow, and M.D. Cohen Backing into cancer: effects of arsenic on cell differentiation Toxicol. Sci. 65 2 2002 161 163
38. E.T. Snow, M. Schuliga, S. Chouchane, and Y. Hu Sub-toxic arsenite induces a multi-component protective response against oxidative stress in human cells W.R. Chappel C.O. Abernathy R.L. Calderon Arsenic exposure and health effects IV 2001 Elsevier Science Oxford, United Kingdom
39. C. Sonich-Mullin, R. Fielder, J. Wiltse, K. Baetcke, J. Dempsey, P. Fenner-Crisp, D. Grant, M. Hartley, A. Knaap, D. Kroese, I. Mangelsdorf, E. Meek, J.M. Rice, and M. Younes IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis Regul. Toxicol. Pharmacol. 34 2 2001 146 152
40. U.S. Environmental Protection Agency (USEPA), 1985. Drinking Water Criteria Document for Nitrates/Nitrites. Office of Drinking Water, Washington, DC
41. U.S. Environmental Protection Agency (USEPA), 1986. Guidelines for Carcinogen Risk Assessment. Federal Register 51 (185), 33992-43003
42. U.S. Environmental Protection Agency (USEPA), 1987. Update To The Health Assessment Document And Addendum For Dichloromethane (Methylene Chloride): Pharmacokinetics, Mechanism Of Action, And Epidemiology. External Review Draft. EPA/600/8-87/030A. Office of Health and Environmental Assessment, USEPA, Washington, DC
43. U.S. Environmental Protection Agency (USEPA), 1988. Thyroid Follicular Cell Carcinogenesis: Mechanistic and Science Policy Considerations, EPA/625/3-88/014A, Review Draft. Risk Assessment Forum, USEPA, Washington, DC
44. U.S. Environmental Protection Agency (USEPA), 1991. Alpha 2u-Globulin: Association with Chemically Induced Renal Toxicity and Neoplasia in the Male Rat. EPA/625/3 91/019F. Risk Assessment Forum, USEPA, Washington, DC
45. U.S. Environmental Protection Agency (USEPA), 1994. Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry EPA/600/8-90/066F. Office of Health and Environmental Assessment, USEPA, Washington, DC
46. U.S. Environmental Protection Agency (USEPA), 1999. Toxicological Review of Ethylene Glycol Monobutyl Ether (EGBE) in Support of Summary Information on the Integrated Risk Information System (IRIS). EPA/635-R00/004. National Center for Environmental Assessment, USEPA, Washington, DC
47. U.S. Environmental Protection Agency (USEPA), 2000a. Toxicological Review of Vinyl Chloride in Support of Summary Information on the Integrated Risk Information System (IRIS). EPA/635-R00/004. National Center for Environmental Assessment, USEPA, Washington, DC
48. U.S. Environmental Protection Agency (USEPA), 2001a. National-Scale Air Toxics Assessment for 1996. EPA-453/R-01-003. Office of Air Quality Planning and Standards, USEPA, Research Triangle Park, NC
49. U.S. Environmental Protection Agency (USEPA), 2001b. Toxicological Review of Chloroform in Support of Summary Information on the Integrated Risk Information System (IRIS). EPA/635-R01/001. National Center for Environmental Assessment, USEPA, Washington, DC
50. U.S. Environmental Protection Agency (USEPA), 2001c. Trichloroethylene (TCE) Health Risk Assessment: Synthesis and Characterization. External Review Draft. EPA/600/P-01/002A. National Center for Environmental Assessment, USEPA, Washington, DC
51. US Environmental Protection Agency (USEPA), 2001d. National Primary Drinking Water Regulations: Arsenic and Clarifications to Compliance and New Source Contaminants Monitoring. Final Rule. 40 CFR Parts 141 and 142, Fed. Reg. 66 (14), 6976-7066
52. U.S. Environmental Protection Agency (USEPA), 2002a. Guidance on Cumulative Risk Assessment of Pesticide Chemicals That Have a Common Mechanism of Toxicity. Office of Pesticide Programs, USEPA, Washington, DC
53. U.S. Environmental Protection Agency (USEPA), 2002b. Toxicological Review of 1,1-Dichloroethylene in Support of Summary Information on the Integrated Risk Information System (IRIS). EPA/635-R01/001. National Center for Environmental Assessment, USEPA, Washington, DC
54. U.S. Environmental Protection Agency (USEPA), 2002c. Perchlorate Environmental Contamination: Toxicological Review and Risk Characterization. External Review Draft. NCEA-1-0503. Office of Research and Development, USEPA, Washington, DC
55. U.S. Environmental Protection Agency (USEPA), 2002d. Toxicological Review of Boron and Compounds in Support of Summary Information on the Integrated Risk Information System (IRIS). External Review Draft. National Center for Environmental Assessment, USEPA, Washington, DC
56. U.S. Environmental Protection Agency (USEPA), 2003a. Draft Final Guidelines for Carcinogen Risk Assessment. EPA/630/P-03/001A. Risk Assessment Forum, USEPA, Washington, DC
57. U.S. Environmental Protection Agency (USEPA), 2003b. Exposure and Human Health Reassessment of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) and Related Compounds Part III: Integrated Summary and Risk Characterization for 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) and Related Compounds. SAB Review Draft. EPA/600/P-00/001Cb. National Center for Environmental Assessment, USEPA, Washington, DC
58. U.S. Environmental Protection Agency Science Advisory Board (USEPA SAB), 2002. Review of Draft Trichloroethylene Health Risk Assessment: Synthesis and Characterization: An EPA Science Advisory Board Report. EPA-SAB-EHC-03-002
59. J. Whysner, and G.M. Williams Butylated hydroxyanisole mechanistic data and risk assessment: conditional species-specific cytotoxicity, enhanced cell proliferation, and tumor promotion Pharmacol. Ther. 71 1-2 1996 137 151
60. J. Whysner, and G.M. Williams Saccharin mechanistic data and risk assessment: urine composition, enhanced cell proliferation, and tumor promotion Pharmacol. Ther. 71 1-2 1996 225 252